Get the Stockscreener App
69.58
0.32%
-0.22
After Hours:
69.58
Merus N V stock is traded at $69.58, with a volume of 1.24M.
It is down -0.32% in the last 24 hours and up +9.11% over the past month.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
See More
Previous Close:
$69.80
Open:
$70
24h Volume:
1.24M
Relative Volume:
1.86
Market Cap:
$5.26B
Revenue:
$35.93M
Net Income/Loss:
$-244.56M
P/E Ratio:
-17.62
EPS:
-3.95
Net Cash Flow:
$-157.31M
1W Performance:
+3.13%
1M Performance:
+9.11%
6M Performance:
+41.54%
1Y Performance:
+41.60%
1-Day Range:
$68.55
$70.25
1-Week Range:
$65.74
$70.65
52-Week Range:
$33.19
$70.65
Merus N V Stock (MRUS) Company Profile
Name
Merus N V
Sector
Industry
Phone
31 030 253 8800
Address
YALELAAN 62, 3584 CM UTRECHT
Compare MRUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRUS
Merus N V
|
69.58 | 5.08B | 35.93M | -244.56M | -157.31M | -3.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Merus N V Stock (MRUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Initiated | Alliance Global Partners | Buy |
| Feb-13-25 | Initiated | Piper Sandler | Overweight |
| Feb-07-25 | Initiated | Wells Fargo | Overweight |
| Nov-21-24 | Initiated | Goldman | Buy |
| Oct-24-24 | Initiated | UBS | Buy |
| Mar-28-24 | Initiated | Truist | Buy |
| Mar-04-24 | Reiterated | Needham | Buy |
| Nov-02-23 | Initiated | Canaccord Genuity | Buy |
| Aug-21-23 | Initiated | TD Cowen | Outperform |
| Aug-02-22 | Initiated | Stifel | Buy |
| Feb-11-22 | Initiated | BMO Capital Markets | Outperform |
| Feb-10-22 | Initiated | Needham | Buy |
| Nov-17-21 | Resumed | Guggenheim | Buy |
| Jun-07-21 | Upgrade | Citigroup | Neutral → Buy |
| Apr-08-21 | Initiated | William Blair | Outperform |
| Mar-16-21 | Initiated | SVB Leerink | Outperform |
| Jun-26-20 | Initiated | H.C. Wainwright | Buy |
| May-27-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-20-19 | Resumed | Guggenheim | Buy |
| Jun-28-19 | Initiated | ROTH Capital | Buy |
| Apr-12-19 | Resumed | Guggenheim | Buy |
| Apr-03-19 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-27-19 | Initiated | Berenberg | Buy |
| Jan-02-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-15-17 | Initiated | RBC Capital Mkts | Outperform |
| Mar-21-17 | Downgrade | Citigroup | Buy → Neutral |
| Dec-22-16 | Upgrade | Citigroup | Neutral → Buy |
| Nov-07-16 | Downgrade | Citigroup | Buy → Neutral |
| Jun-13-16 | Initiated | Citigroup | Buy |
| Jun-13-16 | Initiated | Guggenheim | Buy |
| Jun-13-16 | Initiated | Wedbush | Outperform |
View All
Merus N V Stock (MRUS) Latest News
Polar Asset Management Partners Inc. Decreases Holdings in Merus N.V. $MRUS - MarketBeat
Merus NV stock hits all-time high of 69.64 USD By Investing.com - Investing.com Nigeria
Alliancebernstein L.P. Lowers Stock Position in Merus N.V. $MRUS - MarketBeat
Samlyn Capital LLC Sells 288,750 Shares of Merus N.V. $MRUS - MarketBeat
Cinctive Capital Management LP Makes New $520,000 Investment in Merus N.V. $MRUS - MarketBeat
Alyeska Investment Group L.P. Lowers Stock Position in Merus N.V. $MRUS - MarketBeat
Merus NV stock hits all-time high of 69.64 USD - Investing.com
Woodline Partners LP Increases Holdings in Merus N.V. $MRUS - MarketBeat
Parkman Healthcare Partners LLC Sells 17,450 Shares of Merus N.V. $MRUS - MarketBeat
Granahan Investment Management LLC Sells 8,842 Shares of Merus N.V. $MRUS - MarketBeat
Merus N.V.’s Promising Phase 3 Study on Head and Neck Cancer Treatment - MSN
Merus N.V.’s Phase 3 Study on Petosemtamab: A Potential Game-Changer for Head and Neck Cancer - MSN
Boothbay Fund Management LLC Increases Stock Position in Merus N.V. $MRUS - MarketBeat
Trexquant Investment LP Decreases Position in Merus N.V. $MRUS - MarketBeat
BofA Securities reiterates Buy rating on Merus stock, citing strong outlook By Investing.com - Investing.com South Africa
BofA Securities reiterates Buy rating on Merus stock, citing strong outlook - Investing.com
ADAR1 Capital Management LLC Sells 14,500 Shares of Merus N.V. $MRUS - MarketBeat
Ally Bridge Group NY LLC Cuts Position in Merus N.V. $MRUS - MarketBeat
Market Review: Is Merus N.V. forming a breakout patternJuly 2025 WrapUp & Risk Controlled Swing Trade Alerts - classian.co.kr
Baker BROS. Advisors LP Sells 226,500 Shares of Merus N.V. $MRUS - MarketBeat
Earnings visualization tools for Merus N.V.Trade Analysis Summary & Target Return Focused Picks - Newser
What moving averages say about Merus N.V.2025 Breakouts & Breakdowns & Trade Opportunity Analysis Reports - Newser
Can Merus N.V. hit a new high this month2025 Year in Review & Stepwise Trade Signal Guides - Newser
Will Merus N.V. outperform during market ralliesDollar Strength & AI Driven Stock Price Forecasts - خودرو بانک
Walleye Capital LLC Takes Position in Merus N.V. $MRUS - MarketBeat
Historical volatility pattern of Merus N.V. visualized2025 Stock Rankings & Real-Time Chart Breakout Alerts - Newser
Using data models to predict Merus N.V. stock movementJuly 2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Intraday pattern recognizer results for Merus N.V.Weekly Trade Analysis & Verified Momentum Stock Alerts - Newser
What does recent volatility data suggest for Merus N.V.Weekly Volume Report & Entry Point Confirmation Signals - Newser
Is Merus N.V. gaining market shareJuly 2025 PostEarnings & Weekly High Return Stock Forecasts - خودرو بانک
Applying big data sentiment scoring on Merus N.V.Long Setup & Fast Momentum Entry Tips - Newser
Is Merus N.V. a defensive stockJuly 2025 Analyst Calls & Free High Return Stock Watch Alerts - خودرو بانک
Merus N.V. $MRUS Shares Acquired by Paradigm Biocapital Advisors LP - MarketBeat
Evaluating Merus N.V. with trendline analysisIPO Watch & Target Return Focused Stock Picks - Newser
Is Merus N.V. forming a breakout pattern2025 EndofYear Setup & Weekly High Potential Stock Alerts - خودرو بانک
Is Merus N.V. forming higher highs and higher lows2025 Analyst Calls & Growth Focused Stock Pick Reports - خودرو بانک
How to integrate Merus N.V. into portfolio analysis toolsJuly 2025 Earnings & Capital Efficiency Focused Ideas - Newser
Chart overlay techniques for tracking Merus N.V.Watch List & Growth Focused Entry Point Reports - Newser
How to use Fibonacci retracement on Merus N.V.2025 Price Action Summary & High Conviction Investment Ideas - Newser
Building trade automation scripts for Merus N.V.2025 Market Sentiment & AI Driven Stock Movement Reports - Newser
Merus N.V. stock trendline breakdownPortfolio Value Report & Technical Confirmation Trade Alerts - Newser
Is it time to cut losses on Merus N.V.Quarterly Portfolio Summary & AI Enhanced Execution Alerts - Newser
Merus N.V. $MRUS is DAFNA Capital Management LLC's 4th Largest Position - MarketBeat
Backtesting results for Merus N.V. trading strategiesWeekly Profit Summary & Consistent Return Investment Signals - Newser
Visual analytics tools that track Merus N.V. performanceQuarterly Earnings Report & Safe Capital Growth Stock Tips - Newser
How to recover losses in Merus N.V. stockWeekly Volume Report & Verified Stock Trade Ideas - Newser
Institution Moves: What are the analyst revisions for ASRVIs Merus N.V. stock a good investment in YEARJuly 2025 Outlook & Reliable Trade Execution Plans - خودرو بانک
Merus N V Stock (MRUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):